ID: ALA2115081

Max Phase: Preclinical

Molecular Formula: C19H19Cl2N3O3

Molecular Weight: 408.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H](Cc1ccccc1)C(=O)N[C@H]1C[C@H](C(=O)O)Nc2cc(Cl)cc(Cl)c21

Standard InChI:  InChI=1S/C19H19Cl2N3O3/c20-11-7-12(21)17-14(8-11)23-16(19(26)27)9-15(17)24-18(25)13(22)6-10-4-2-1-3-5-10/h1-5,7-8,13,15-16,23H,6,9,22H2,(H,24,25)(H,26,27)/t13-,15-,16+/m0/s1

Standard InChI Key:  OSAJXCHDZBNJAK-CWRNSKLLSA-N

Associated Targets(non-human)

Glutamate (NMDA) receptor subunit zeta 1 2166 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate NMDA receptor 6467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 408.29Molecular Weight (Monoisotopic): 407.0803AlogP: 2.99#Rotatable Bonds: 5
Polar Surface Area: 104.45Molecular Species: ACIDHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.51CX Basic pKa: 8.01CX LogP: 0.27CX LogD: 0.19
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -0.11

References

1. Leeson PD, Carling RW, Moore KW, Moseley AM, Smith JD, Stevenson G, Chan T, Baker R, Foster AC, Grimwood S..  (1992)  4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.,  35  (11): [PMID:1534584] [10.1021/jm00089a004]

Source